Sponsors
The bill caps annual out-of-pocket prescription costs for individuals and families—providing predictable financial protection for people who use medicines—at the trade-off of potential premium increases, insurer cost‑containment strategies that could limit access to some drugs, and some short-term implementation uncertainty for plans and regulators.
People with self-only health plans will have their annual prescription drug out-of-pocket costs capped at $2,000 beginning in 2027, reducing high spending for individuals who use medicines regularly.
Households (families and non–self-only enrollees) will face a predictable annual drug cost cap equal to twice the self-only amount, limiting catastrophic prescription spending for families.
Many marketplace and large-group plans that are subject to essential health benefits will be covered by these caps, giving enrollees and health systems more predictable maximum drug costs starting in 2027.
Some insurers may respond to reduced cost‑sharing revenue by narrowing drug formularies, increasing prior authorization requirements, or using narrow provider networks, which could restrict access to specific medicines or disrupt continuity of care for patients.
Taxpayers or plan sponsors could face higher premiums if insurers raise premiums to offset lower out-of-pocket revenue from drug users, shifting costs to broader groups including middle-class families and employers.
Unclear or incomplete conforming amendments in the statutory text could cause implementation confusion for plans and regulators, creating administrative uncertainty for state and local governments and for plans until final guidance is issued.
Based on analysis of 2 sections of legislative text.
Imposes an annual cap on prescription drug cost-sharing in EHB plans: $2,000 self-only in 2027 (indexed thereafter) and twice that for other-than-self-only coverage.
Introduced November 20, 2025 by Jake Auchincloss · Last progress November 20, 2025
Sets a new annual dollar cap on how much covered people must pay out of pocket for prescription drugs in plans that must cover essential health benefits. For plan years starting on or after January 1, 2027, the cap is $2,000 for self-only coverage in 2027 (then indexed in later years) and twice that amount for other-than-self-only coverage. The change is implemented by amending the Affordable Care Act’s cost-sharing rules to add a drug-specific cost-sharing limit, update related cross-references, and apply the limit to plans subject to essential health benefits rules.